KP Tissue (TSX:KPT) ROCE % : 0.00% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is KP Tissue ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. KP Tissue's annualized ROCE % for the quarter that ended in Dec. 2024 was 0.00%.

KP Tissue ROCE % Historical Data

The historical data trend for KP Tissue's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KP Tissue ROCE % Chart

KP Tissue Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

KP Tissue Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

KP Tissue ROCE % Calculation

KP Tissue's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	0	/	( ( (70.607 - 2.25)	+	(71.315 - 1.798) )	/ 2 )
	=	0	/	( (68.357	+	69.517)	/ 2 )
	=	0	/	68.937
	=	0.00 %

KP Tissue's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	0	/	( ( (72.875 - 2.172)	+	(71.315 - 1.798) )	/ 2 )
	=	0	/	( ( 70.703	+	69.517 )	/ 2 )
	=	0	/	70.11
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

KP Tissue (TSX:KPT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

KP Tissue ROCE % Related Terms

Thank you for viewing the detailed overview of KP Tissue's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

KP Tissue Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » KP Tissue Inc (TSX:KPT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

KPTSF:USA

Address

2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8

Website

https://www.kptissueinc.com

KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.

Executives

Mario Gosselin	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Michael Keays	Senior Officer
David A Spraley	Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Sarah Astrea Kruger	Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Dino Joe Bianco	Director, Senior Officer
David Angel	Director or Senior Officer of 10% Security Holder
Michel Letellier	Director

KP Tissue Headlines

No Headlines